PRKAA1预测预后,并且与胃癌的免疫特征有关

Yongyi Chen1,2, Siyu Chen1,2, Jing Zhu1,2

  • 1Zhejiang Cancer Hospital, Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Hangzhou, Zhejiang, 310022, China.

概括

高表达PRKAA1,5-AMP激活蛋白激酶的α子单元,与晚期胃癌 (GC) 和低生存率有关. PRKAA1可能作为GC的预后生物标志物,与免疫细胞透相关.